ArticleFrontiers in immunology2019

Autologous Hematopoietic Stem Cells Are a Preferred Source to Generate Dendritic Cells for Immunotherapy in Multiple Myeloma Patients.

Prajakta Shinde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.